The objective of the studies proposed in this application is to identify genotypic combinations of mice and mycobacteria that result in significant alterations of host responses to experimental mycobacterial infection. Susceptibility or resistance to experimental infection will be defined by determination of median survival time, weight loss, mycobacterial load in the lung and spleen, and in addition various immunological parameters in lung and other tissues. In these experiments, the host genome will be varied by use of 37 recombinant congenic strains (RCS), which are derived from inbred progenitors that are either susceptible to tuberculosis (A/J, abbreviated A) or resistant to tuberculosis (C57BL/6J, abbreviated B). The AcB/BcA RCS are now fully inbred and genotyped with a dense set of genome-wide microsatellite markers. These strains will be infected with a panel of Mycobacterium tuberculosis and M. bovis strains that have been deleted for genome regions associated with attenuation of BCG vaccines. The infection protocol in the RCS will reveal informative, significant deviations from the """"""""expected"""""""" or """"""""parental"""""""" disease phenotypes which signify the presence of quantitative trait loci (QTL) with strong effect on phenotype expression and possibly specific gene(s) interaction between the host and pathogen. In RCS carrying QTL with strong effect on phenotype expression, changes in gene expression level in both lung macrophages and intracellular mycobacteria will be revealed by microarray analysis. The knowledge to what extent host responses in mycobacterial infections are a reflection of specific host pathogen combinations will be crucial for our understanding of the epidemiological flow of M. tuberculosis through an exposed population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL068533-01
Application #
6412492
Study Section
Special Emphasis Panel (ZHL1-CSR-L (M4))
Program Officer
Peavy, Hannah H
Project Start
2001-09-14
Project End
2006-07-31
Budget Start
2001-09-14
Budget End
2002-07-31
Support Year
1
Fiscal Year
2001
Total Cost
$300,000
Indirect Cost
Name
Mcgill University
Department
Type
DUNS #
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 0-G4
Di Pietrantonio, Tania; Correa, Jose A; Orlova, Marianna et al. (2011) Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection. Infect Immun 79:2372-8
Di Pietrantonio, Tania; Hernandez, Carmen; Girard, Manon et al. (2010) Strain-specific differences in the genetic control of two closely related mycobacteria. PLoS Pathog 6:e1001169
Fortune, S M; Jaeger, A; Sarracino, D A et al. (2005) Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A 102:10676-81
Di Pietrantonio, Tania; Schurr, Erwin (2005) Mouse models for the genetic study of tuberculosis susceptibility. Brief Funct Genomic Proteomic 4:277-92
Guinn, Kristi M; Hickey, Mark J; Mathur, Sanjeev K et al. (2004) Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51:359-70
Sherman, David R; Guinn, Kristi M; Hickey, Mark J et al. (2004) Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guerin in long-term murine infection. J Infect Dis 190:123-6
Belley, Adam; Alexander, David; Di Pietrantonio, Tania et al. (2004) Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun 72:2803-9
Volkman, Hannah E; Clay, Hilary; Beery, Dana et al. (2004) Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol 2:e367
Mostowy, Serge; Cleto, Cynthia; Sherman, David R et al. (2004) The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb) 84:197-204
Lewis, Kaeryn N; Liao, Reiling; Guinn, Kristi M et al. (2003) Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 187:117-23